CXCL10 and rheumatoid arthritis: Critically, our study reveals a divergent pathogenic role in CBIA: here, immunoactivating Tregs specifically overproduce MCP1/MCP4 (rather than RA-associated chemokines like CCL11/CXCL10), creating a feedforward loop that sustains synovial inflammation.